Veeva Systems (NYSE:VEEV) Downgraded by Wall Street Zen to “Hold”

Posted by Stanley Muller on Aug 4th, 2026

Wall Street Zen downgraded shares of Veeva Systems (NYSE:VEEV – Free Report) from a buy rating to a hold rating in a research report released on Monday morning.

Several other equities research analysts also recently issued reports on VEEV. BTIG Research reiterated a “buy” rating and issued a $340.00 target price on shares of Veeva Systems in a research note on Thursday, June 4th. Needham & Company LLC reiterated a “buy” rating and set a $270.00 price target on shares of Veeva Systems in a report on Thursday, June 4th. Wells Fargo & Company boosted their price target on Veeva Systems from $317.00 to $320.00 and gave the stock an “overweight” rating in a research report on Thursday, June 4th. Mizuho dropped their price objective on Veeva Systems from $295.00 to $270.00 and set an “outperform” rating on the stock in a research note on Thursday, June 4th. Finally, BNP Paribas Exane reaffirmed an “outperform” rating and issued a $285.00 price objective on shares of Veeva Systems in a research report on Thursday, June 4th. One research analyst has rated the stock with a Strong Buy rating, eighteen have given a Buy rating, eight have given a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus target price of $247.08.

Check Out Our Latest Report on VEEV

Veeva Systems Trading Up 1.1%

NYSE VEEV opened at $206.11 on Monday. Veeva Systems has a 12 month low of $148.05 and a 12 month high of $310.50. The stock has a 50 day moving average of $179.48 and a 200-day moving average of $179.88. The company has a market cap of $33.48 billion, a PE ratio of 36.74, a PEG ratio of 0.88 and a beta of 0.94.

Veeva Systems (NYSE:VEEV – Get Free Report) last issued its earnings results on Wednesday, June 3rd. The technology company reported $2.24 earnings per share for the quarter, topping analysts’ consensus estimates of $2.14 by $0.10. Veeva Systems had a net margin of 28.37% and a return on equity of 13.72%. The business had revenue of $882.95 million for the quarter, compared to the consensus estimate of $857.73 million. During the same period in the previous year, the company earned $1.97 earnings per share. The firm’s revenue for the quarter was up 16.3% on a year-over-year basis. Veeva Systems has set its FY 2027 guidance at 9.050-9.050 EPS and its Q2 2027 guidance at 2.210-2.220 EPS. As a group, sell-side analysts predict that Veeva Systems will post 6.65 EPS for the current fiscal year.

Institutional Trading of Veeva Systems

Hedge funds have recently modified their holdings of the stock. Norges Bank acquired a new stake in Veeva Systems during the fourth quarter worth approximately $332,412,000. Durable Capital Partners LP acquired a new position in shares of Veeva Systems in the second quarter valued at approximately $281,351,000. Arrowstreet Capital Limited Partnership grew its position in shares of Veeva Systems by 203.0% in the first quarter. Arrowstreet Capital Limited Partnership now owns 913,281 shares of the technology company’s stock valued at $160,427,000 after purchasing an additional 611,868 shares during the last quarter. AQR Capital Management LLC grew its position in shares of Veeva Systems by 31.2% in the third quarter. AQR Capital Management LLC now owns 2,412,210 shares of the technology company’s stock valued at $706,078,000 after purchasing an additional 574,164 shares during the last quarter. Finally, Swedbank AB increased its stake in shares of Veeva Systems by 43.5% during the first quarter. Swedbank AB now owns 1,645,128 shares of the technology company’s stock worth $288,983,000 after purchasing an additional 498,971 shares during the period. Institutional investors and hedge funds own 88.20% of the company’s stock.

Veeva Systems Company Profile

(Get Free Report)

Veeva Systems (NYSE: VEEV) is a cloud software company that develops industry-specific applications and data solutions for the global life sciences sector. Founded in 2007 and headquartered in Pleasanton, California, Veeva focuses on helping pharmaceutical, biotechnology, medical device and consumer health companies manage regulated content, clinical and regulatory processes, quality systems, and commercial operations in a compliant, cloud-native environment. The company completed its initial public offering in 2013 and has since expanded its product suite and international footprint.

Veeva’s product portfolio centers on its Vault platform and related application suites, which provide content and data management, clinical trial and regulatory workflows, quality management, and structured commercial capabilities such as customer relationship management and promotional content management.